We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, seperating it from the asset price movements caused by...

We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, separating it from the asset price movements caused by...

We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, separating it from the asset price movements caused by...

Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...